WuXi XDC’s Post

There are many emerging Biopharmas listed here. To me it looks totally different from what was 10 years, or even 5 years ago. "The top 10 list is based on Evaluate’s 2024 preview, where the analysts assess what they see as the biggest-selling drugs that will be approved this year in terms of sales by 2028. Check out the top 10 most anticipated drug launches of the year below. You can find last year's edition here." https://lnkd.in/gPgydAW7

🌟 Today's article highlight is "A Practical and Efficient Method for the Synthesis of Sorafenib and Regorafenib" by Ramteke Prachi and Manjinder Singh Gill from National Institute of Pharmaceutical Education and Research (NIPER), India. This study presents a sustainable approach to synthesizing two anticancer drugs, addressing challenges found in traditional methods. 💡 Key Highlights: 👉 No need for an inert atmosphere 👉 Water-assisted carbamate formation 👉 Phosgene- and isocyanate-free process for safer production 🔓 Read the full #OpenAccess article on our website: https://lnkd.in/dTZw9-wP #OrganicChemistry #GreenSynthesis #PharmaceuticalResearch #Sorafenib #Regorafenib

Get a list of Simson Pharma's newly synthesized products by scanning. https://lnkd.in/deU9THuQ #impuritystandards #isotopelabelledcompounds #metabolites #workingstandards #simsonpharma #newlysynthesizedproducts

The journey from molecule to medicine to market is undeniably complex, but isn’t necessarily one you must travel on alone. You deserve a trustworthy #CDMO by your side at every step — a partner that prioritizes intangible elements like communication, dedication, collaboration, and foresight. Come discover what you’ve been missing at #DCATWeek 2024. Schedule a private meeting with Thermo Fisher Scientific experts to learn how we embed these elements into every operation, interaction, and step across your unique #drugdevelopment journey. Find your missing element at DCAT Week: http://spr.ly/6045poTm3 DCAT (Drug, Chemical & Associated Technologies Association) #DCAT #DCAT2024 #pharma #biopharma #pharmaceuticalmanufacturing

We're thrilled to share that BioDuro-Sundia will be attending INTERPHEX in NYC from April 16-18! 🗽Get on our calendar and schedule a meeting today: https://buff.ly/422N4Ns INTERPHEX is the premier global event in pharmaceutical and biotechnology industries, seamlessly blending industry innovation with expert-led conferences. It's the epicenter where the freshest ideas are exchanged, cutting-edge technology is unveiled, and the transformative power of science through commercialization truly comes to life. No matter your position in the pharmaceutical development lifecycle, INTERPHEX offers tailored solutions to drive growth and accelerate scalability for your business. ✨ Meet Bhavishya Mittal, Vice-President of Product Development and Manufacturing, who will represent BioDuro-Sundia at this prestigious event. ✨ As a Contract Research, Development, and Manufacturing Organization (CRDMO), we're eager to connect with clients, explore collaboration opportunities, and foster innovation. Don't miss this chance to network, learn, and elevate your pharmaceutical endeavors! #BioDuroSundia #INTERPHEX #PharmaceuticalInnovation #Biotechnology #CRDMO #Networking #CollaborationOpportunities #Science #Commercialization #NYCEvents

Drug development teams often find that there is just not a good central library for even really important results, like impurity profiles. While one is in the heat of a drug development program, observations that aren't important today, but might be crucial later, can be lost. Use SimpliDATA to help keep track. #drugdevelopment #techtransfer #pharma #technology

Thoughts on this? >> Takeda signs option deal for TKI inhibitor; Enveda's $55M raise >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #healthcare #pharma #productmarketing

Closed System Drug Transfer Device (CSTD) Research：CAGR of 18.2% during the forecast period https://lnkd.in/ePYMMQGs #marketanalysis #marketresearch #marketresearchreports #businessintelligence

Thoughts on this? >> Takeda signs option deal for TKI inhibitor; Enveda's $55M raise >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharma #healthcare #pharmaceutical

Compeutional drug design a& discovery is the tool for futuristic drugs manufacturing #Molecular_docking #DFT #ADME_Study #Pharmacophore #Dynamic_Simulation